NCT04158466View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens

NACompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

May 31, 2019

Primary Completion Date

November 12, 2019

Study Completion Date

November 12, 2019

Conditions
Contact Lens Wear
Interventions
DEVICE

Kalifilcon A Daily Disposable Contact Lenses

Contact lens

DEVICE

Biotrue ONEday Daily Disposable Contact Lenses

Contact lens

Trial Locations (16)

13850

Bausch Site 13, Vestal

16801

Bausch Site 2, State College

34237

Bausch Site 6, Sarasota

37027

Bausch Site 14, Brentwood

37205

Bausch Site 3, Nashville

38119

Bausch Site 5, Memphis

53151

Bausch Site 15, New Berlin

61701

Bausch Site 11, Bloomington

63144

Bausch Site 1, St Louis

66762

Bausch Site 7, Pittsburg

90012

Bausch Site 8, Los Angeles

90503

Bausch Site 10, Torrance

90505

Bausch Site 12, Torrance

94112

Bausch Site 9, San Francisco

96701

Bausch Site 4, ‘Aiea

96814

Bausch Site 16, Honolulu

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT04158466 - A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens | Biotech Hunter | Biotech Hunter